Zhitong Finance App News, Rongchang Biotech (09995.HK) issued an announcement. Currently, the company's production and operation are all normal, the supply chain is stable, the production capacity guarantee is sufficient, the commercialization of core products is progressing steadily, and the overall quality of operation continues to improve.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.